Context: Pendred syndrome is caused by mutations in the gene coding for pendrin, an apical Cl
transport of iodide (16) . Consequently, a lack of pendrin is associated with a partial defect in iodide transport responsible for the development of moderate diffuse to large multinodular goiters. Most of PDS patients are euthyroid but progressively develop subclinical hypothyroidism (5, 17) .
In the chain of events leading to thyroid hormone synthesis, the transport of iodide across the apical membrane through pendrin (16) follows its active uptake at the basal pole of thyroid cells by the sodium-iodide symporter (NIS) (18) . Hence, iodide is organified and incorporated into thyroglobulin (Tg) as iodotyrosines (monoiodotyrosine and diiodotyrosine) by the thyroid peroxidase (TPO), requiring H 2 O 2 as cofactor. H 2 O 2 is generated by dual oxidases (Duoxs) (19, 20) . TPO also catalyzes the coupling of iodotyrosines to form T 3 and T 4 . Tg-containing hormones are then stocked in the colloid until further use. Tg is eventually reabsorbed by follicular cells and digested in lysosomes to produce T 4 and T 3 that are released into the blood stream. Unused MIT and diiodotyrosine are degraded by transmembrane iodotyrosine dehalogenase (DEHAL1), thereby recycling iodide into the colloid for ulterior cycles of hormone synthesis (21) .
The differences in residual thyroid function among PDS patients, as well as the controversial literature about the role of pendrin as apical transporter of iodide, prompted us to investigate changes in the expression of proteins involved in the thyroid hormone synthesis in the thyroid tissue from a hypothyroid PDS patient with a large goiter.
Materials and Methods

Thyroid samples
Thyroid samples from a PDS patient and four patients with multinodular goiter were obtained at surgery, with the patients' informed consent. Additional normal tissues obtained from patients operated for single nodules were used as control for iodide uptake and H 2 O 2 generation measurements.
The PDS patient was a 55-yr-old female patient with a biallelic V138F mutation of the SLC26A4 gene encoding pendrin. This mutation is a missense mutation already described (22) . She presented with severe bilateral deafness and a multinodular goiter detected 25 yr ago. She was treated with T 4 (125 g/d). A total thyroidectomy was carried out in 2007. The thyroid clinical pa-
FIG. 1.
A, Expression of pendrin and Tg-I and PAS staining. Pendrin was detected by immunohistochemistry and WB in control thyroids. Its localization was apical. In PDS samples, no pendrin was detected. Scale bars, 40 m. Pendred sections stained with PAS exhibited a great heterogeneity compared with the control tissues. Two zones were defined: zone 1 contained encapsulated clusters of normal follicles (1) filled with glycoprotein, as seen in control thyroid follicles. Zone 2 contained destroyed follicles (2) . Death cells and inflammatory cells were observed in the lumen of destroyed follicles (zone 2, insert). Tg-I was detected in all control follicles. In zone 1, some follicles contained Tg-I (zone 1.a), whereas others remained negative (zone 1.b). Scale bars, 100 m; insert, 40 m. B, Immunodetection of Tg, Tg-I, and T 4 . In follicles from zone 1.a, Tg was detected in the lumen, as in control follicles. In zone 1.b, in addition to colloid, Tg was also expressed in the cytoplasm. Tg-I was detected in the colloid of control and PDS zone 1.a follicles. In zone 1.b, no Tg-I was detected. T 4 was detected in the colloid alone, solely in control thyroids. In zone 1.a, T 4 was also detected as inclusions in the thyrocyte cytoplasm in addition to colloid. In zone 1.b, T 4 was detected only in the intracellular compartment, the colloid remaining negative. Scale bars, 40 m; insert, 10 m. rameters at surgery were 3.25 IU/ml TSH and 19.3 ng/ml free T 4 , indicating that the patient was euthyroid at the time of surgery.
The detection of pendrin in thyroid cells was performed by immunochemistry and Western blots (WBs) using an antibody directed against the C-terminal region of pendrin (amino acids 766 -780) (23) . Whereas in normal thyroid tissues pendrin was detected as expected at the apical membrane, it was detected by neither immunohistochemistry nor WB in the PDS thyroid (Fig.1A) .
Iodide uptake and H 2 O 2 generation
Several biological variables were measured in slices of PDS thyroid tissue in comparison with normal tissues obtained from patients operated for single nodules. Iodide uptake and H 2 O 2 generation were measured as previously described (24, 25) . Iodide uptake was measured in the presence of methimazole (1 mM) as tissue to medium ratio of radioiodide in experimental vs. NaClO 4 (1 mM)-incubated slices.
Preparation of tissue samples
Thyroid fragments were fixed in buffered-formalin and embedded in paraffin. Thick sections (5 m) were used for histology and immunohistochemistry. Other fragments were rapidly frozen, and cryostat sections (5 m) were used for Duox immunohistochemistry. For 127 I detection on semithin sections (0.5 m), fragments were fixed in 2.5% glutaraldehyde in 0.1 M cacodylate buffer for 1.5 h and embedded in LX112 resin. Ultrathin sections were stained with uranyl acetate and lead citrate and examined with an electron microscope (LEO 922; Zeiss, Jena Germany). Other fragments were frozen in liquid nitrogen and conserved at Ϫ80 C until use for RT-PCR and WB.
Thyroid histology and glycoprotein staining
Glycoproteins were detected on paraffin sections using the periodic acid-Schiff staining (PAS). Sections were stained with 0.5% periodic acid for 30 min and then with the Schiff's reagent for 20 min. After washing in running tap water for 5 min, nuclei were counterstained with hematoxylin for 3 min.
Immunohistochemistry
Duox was detected on frozen sections. All the other proteins, Tg, iodine-rich Tg (Tg-I), T 4, NIS, pendrin, TPO, activated caspase-6, cyclin D1, caveolin 1 (Cav-1), catalase, peroxiredoxin 5 (PRDX5), 4-hydroxynonenal (HNE), DEHAL1, and ClC-5 were detected on paraffin sections, as previously described (26, 27) . The sections for detection of Cav-1, caspase-6, cyclin D1, HNE, DEHAL1, and catalase were subjected to microwave pretreatment. The staining conditions are summarized in Table 1 . Negative controls included the absence of primary antibody and its replacement by the preimmune serum when available. Controls for Tg-I and T 4 immunostainings were performed by preincubating the first antibody with T 4 .
Ultrastructural distribution of iodine
The ultrastructural distributions of the iodine and phosphorus natural isotope ( 127 I and 31 P) were performed with a Nano-SIMS 50 (Cameca, Gennevilliers, France) using a Cs ϩ primary bombardment accelerated at 8 keV and a current above 1 pA. Under these conditions, a lateral resolution of 100 nm is expected. The polarity of the sample was negative (8 KeV) and allowed the detection of negative ions (28 -31) . The detection of these elements was done in the multicollection mode with parallel detection of 12 C, 12 C 14 N, and 34 S (not shown here). The analyzed surface was 30 ϫ 30 m, and all images were acquired as a matrix of 256 ϫ 256 pixels with a counting time of 20 msec per pixel.
WBs
Two fragments of the PDS thyroid and one fragment per sample of normal thyroids (n ϭ 4) were used. Thyroid homogenates were suspended in Laemmli buffer [50 mM Tris HCl, pH 6.8; 2% sodium dodecyl sulfate (SDS); and 10% glycerol] containing a protease inhibitor cocktail (Sigma, St. Louis, MO). Protein concentration was determined using a BCA protein assay kit (Pierce, Rockford, IL). WBs were performed as previously described (32) . The samples were incubated overnight at 4 C with an antibody raised against the target protein (see Table 2 ). Loading control was performed by incubating the same membranes with anti-␤-actin antibody (1:8000; Sigma).
RNA purification, reverse transcription, and PCR
Samples were homogenized and suspended in TriPure isolation reagent (Roche Diagnostics GmbH, Mannheim, Germany). Total RNA was purified according to the manufacturer's protocol and resuspended in 6 l H 2 O. Reverse transcription and PCR were performed as previously described (32) . Primers and annealing temperatures are described in Table 3 .
Results
The PDS thyroid exhibits marked morphologic heterogeneity The PDS thyroid was highly heterogeneous, with two main morphological zones. The first zone (zone 1) with encapsulated clusters of follicles with a typical morphology and positive PAS coloration was similar to normal thyroids (Fig. 1A) . The second zone (zone 2) was rather large and contained destroyed and PAS-negative follicles with cells of follicular and inflammatory origins (Fig. 1A) in the lumen. This zone was defined as impaired zone. To better characterize the cell function in each zone, we looked at Tg-I by immunohistochemistry. In normal control thyroids, Tg-I was homogenously distributed in all follicular lumina. Noteworthy, in the zone defined as morphologically normal (zone 1), whereas some follicles contained Tg-I in their lumina, other were negative (Fig. 1A) . Thus, the PAS-positive zones were further divided into two different subzones. They were called zone 1.a when the colloid contained Tg-I and zone 1.b when Tg-I staining was negative. In these latter zones, follicles were always small, lined by a cubical epithelium, which is a morphology characteristic of stimulated follicles. They were thus quite different from cold follicles of old mice or normal human goiters that are known to be in a resting state (33, 34) .
The Tg-I-negative follicles accumulate T 4 in the cytosol
Follicles of normal thyroids and zones 1.a and 1.b of the PDS tissue contained Tg in their colloid. Nevertheless, observation at high magnification showed that whereas zone 1.a presented a pattern of immunostaining similar to that of normal thyroids, an intracellular accumulation of Tg was observed in follicles of zone 1.b (Fig. 1B) .
The patterns of Tg-I and T 4 immunostainings (Fig. 1B ) were quite different. In zone 1.a, Tg-I was detected with an increased intensity in the colloid, compared with normal thyroids, and T 4 was detected not only in the colloid as in normal thyroids but also as positive inclusions in the cells. By contrast, in zone 1.b, Tg-I staining was observed in neither the colloid nor cell. But, surprisingly, in zone 1.b, whereas T 4 was not detected in the colloid, an intense staining was observed within the cells. Using Nano-SIMS50 ( Fig.2A) , 127 I was detected in the interstitium and colloid of control thyroids. In Pendred follicles, 127 I was also detected in the interstitium, but in some follicles it appeared as a ring lining the apical membrane, the center of the colloid remaining empty. Of interest, when examined by electron microscopy, the thyroid cells kept their polarization, as shown by the presence of microvilli at the apical pole. In addition, the cytoplasm was enriched with large dense vesicles, compatible with the intracellular accumulation of Tg (Fig. 2B ).
Pendrin inactivation is associated with a mislocation and up-regulated expression of TPO and Duox
NIS was expressed at the basolateral pole of thyrocytes, in both normal and PDS thyroids (Fig. 3) . The RT-PCR analysis of NIS mRNA (Fig. 4E) showed no difference between normal and PDS thyroids, suggesting no impairment in the basal iodide transport. This is consistent with the fact that iodide uptake also remained unchanged. Indeed, the tissue to medium ratio for PDS thyroid slices achieved a steady state after 30 min at 7.3 Ϯ 1.6. In control thyroids, the steady state was reached after 10, 30, and 60 min at 6.2 Ϯ 2.6, 6.8 Ϯ 0.4, and 10.7 Ϯ 1.6, respectively. After the steady state was reached, a NaClO 4 1 mM discharge showed a release of 80% after 10 min in PDS thyroid slices and 79 and 80% after 10 min in normal thyroid slices. In contrast to NIS, TPO and Duox showed aberrant location and expression (Fig. 3) . Both proteins were detected as a line at the apical pole of normal thyrocytes and in zone 1.a of the PDS thyroid. In the zone 1.b, their expression was greatly enhanced but mislocated. They were exclusively detected in the cytosol, without apical distribution. PCR and WB studies confirmed the increased expression of both proteins. In the two analyzed PDS fragments, an increased expression of Duox mRNA (Fig. 4A) and protein (Fig. 4B) 4D ) expression was also increased but only in the second fragment, reflecting the gland heterogeneity.
Pendrin inactivation is associated with increased DEHAL1 and ClC-5 thyroid expression
In normal thyroids, DEHAL1 was expressed mainly at the apical pole of thyrocytes (Fig. 3) , as previously described (21) . In zone 1.a of the PDS thyroid, DEHAL1 expression was increased and showed an accumulation at the apical pole in addition to its intracytoplasmic location. In zone 1.b, DEHAL1 expression was increased and distributed throughout the cytoplasm.
The chloride/proton exchanger, ClC-5, has been previously shown to be potentially implicated in the apical transport of iodide (35) and is mainly expressed at the apical pole of thyrocytes in normal thyroids (Fig. 3) . ClC-5 expression was increased in zone 1.a of the PDS thyroid. In zone 1.b, the increase was moderate with no apical location. The ClC-5 mRNA expression was enhanced in the first fragment of the PDS thyroid (corresponding to the fragment with moderate increase in Duox and TPO expression), whereas the increase was less important in the second fragment (Fig. 4F) . Thus, we postulate that the first fragment may correspond to a so-called zone 1.a and the second fragment to a zone 1.b. Likewise, it is possible that increased ClC-5 protein expression in still functionally active PDS thyrocytes may compensate, at least transiently, for the lack of pendrin expression.
The aberrant location of Duox and TPO is associated with increased oxidative stress (OS) and expression of antioxidant enzymes
HNE, a product of lipid peroxidation, was used as OS marker (Fig. 3) . HNE was detected at very low levels in normal thyroids and zone 1.a of the PDS thyroid. This staining was greatly increased in zone 1.b.
To face the reactive oxygen species exposure, numerous antioxidant systems are active in the thyroid (36, 37) . We analyzed catalase and PRDX5 expression by immunohistochemistry (Supplemental Fig. 1 , published on The Endocrine Society's Journals Online web site at http://jcem. endojournals.org). In normal thyroids, as well as in zone 1.a of the PDS thyroid, catalase was detected as a light staining in the cytoplasm. Conversely, in zone 1.b of the PDS thyroid, the catalase staining was greatly increased.
FIG. 2. A, Ultrastructural distribution of
31 phosphorus ( 31 P) and 127 iodine ( 127 I) by SIMS imaging. 31 P and 127 I signals were localized using NanoSIMS50 in a normal and the PDS thyroid. 31 P detection gave information on cell morphology. 31 P and 127 I concentrations were evaluated by a color scale ranging from black (Ϫ) to white (ϩ).
127 I was detected at high concentration with a homogeneous distribution in the whole colloid of the control thyroid as well as in the interstitium. In the PDS thyroid, 127 I was still detected in the interstitium but only as a ring in the colloid lining the apical pole of thyrocytes. B, Transmission electron microscopy of the Pendred thyroid. Numerous large intracellular vesicles were observed in cells from the PDS thyroid. Microvilli were always observed at the apical pole of the cells (white arrows), facing the colloid.
PRDX5, which was detected in the cytoplasm and some nuclei in normal thyroids, was slightly increased in zone 1.a of the PDS thyroid. In zone 1.b, PRDX5 expression was greatly increased and its expression was mainly cytoplasmic. Thus, it is likely that increased OS is compensated by higher cytoplasm defenses, such as catalase and PRDX5 activity.
Increased apoptosis in the PDS thyroid is associated with increased cell proliferation and loss of Cav-1 expression
Activated caspase-6, a central player in apoptotic processes, was detected in numerous nuclei of thyrocytes from zone 1.b of the PDS thyroid (Supplemental Fig. 1 ), whereas no staining was observed in the normal tissue or zone 1.a. In parallel, the number of cyclin D1-positive nuclei was also greatly increased in zone 1.b, compared with normal tissue and zone 1.a of the PDS thyroid (Supplemental Fig. 1) . These results suggest an accelerated follicular cell turnover.
Because Cav-1 has been shown to be implicated in regulating cell proliferation as well as the trafficking of Duox and TPO (38), we analyzed its expression in normal and PDS tissues. Cav-1 was detected at the apical pole of the cells in normal thyroids (Fig. 3) and in follicles of zone 1.a of the PDS thyroid. By contrast, no Cav-1 expression was observed in thyrocytes of zone 1.b. Of note, Cav-1 was observed in vessels surrounding these follicles (Fig. 3) .
Discussion
Our results show that the PDS thyroid is characterized by marked tissue heterogeneity. Dispersed between fully destroyed areas (zone 2), particular zones of the PDS thyroid exhibit a normal morphology (zone 1). Some follicles in zone 1 contain Tg and Tg-I in their colloids, and TPO and Duox are expressed near or at the apical pole, as expected (zone 1.a). However,
FIG. 3.
Immunohistodetection of NIS, TPO, Duox, DEHAL1, ClC-5, HNE, and Cav-1. NIS was detected at the basolateral pole of the cells in control as well as in all zones of the PDS thyroids. In control thyroids, TPO and Duox were expressed at the apical pole of the cells. In PDS zone 1.a, TPO and Duox expression was increased but remained localized at the apical pole of the cells. In zone 1.b, TPO and Duox expression was high, but this time located throughout the cells. DEHAL1 was expressed at the apical membrane of normal thyrocytes. In the PDS thyroid, DEHAL1 expression was highly increased. In zone 1.a, DEHAL1 remained localized at the apical pole but was also detected in the cytoplasm. In zone 1.b, the apical location disappeared. ClC-5 was detected as a line at the apical pole of control thyrocytes. In zone 1.a, CLC-5 expression was highly increased and conserved an apical location. In zone 1.b, CLC-5 expression was mainly cytoplasmic and was decreased compared with zone 1.a but remained higher than in normal thyroids. HNE expression was low in control thyroids and zone 1.a and increased in zone 1.b of the PDS thyroid. In control and PDS zone 1.a, Cav-1 was expressed at the apical pole of thyrocytes and in endothelial cells. By contrast, no Cav-1 was detected in thyrocytes from zone 1.b, whereas it remained detected in endothelial cells (black arrows) of this zone. Scale bars, 40 m; insert, 10 m. among follicles that seem morphologically normal, some of them present several abnormalities (zone 1.b). Despite the presence of Tg, there is no Tg-I in the colloid, and T 4 is unexpectedly detected in the cytoplasm. These observations suggest that the thyroid hormone synthesis aberrantly occurs within the cytosol and not at the apical pole of the cell, as expected. This intracellular hormone synthesis coincides with abnormal Duox and TPO localization within the cytosol, whereas NIS expression at the basolateral membrane remains unaffected. Thus, we propose that the three zones observed in the PDS thyroid (zones 1.a, 1.b, and 2) correspond to three successive chronologic states in the outcome of the Pendred disease, from nearly normal morphological and functional follicles to fully destroyed tissue. Considering that the degree and/or kinetic of tissue destruction might be different from one patient to another, one may understand why the phenotype presentation of PDS patients is so variable.
The preserved thyroid function observed in follicles of zone 1.a and the normal uptake and release of iodide in the slices suggests the existence of compensatory mechanisms to face the absence of pendrin. A first compensatory mechanism might be the presence of another apical iodide transporter. This is suggested by the preservation of the thyroid function in some PDS patients who have only mild thyroid dysfunction (5, 17) as well as by the electrophysiological studies using inverted plasma membrane vesicles supporting the participation of at least a second type of iodide channel in the apical efflux of iodide (39) . Among several ion transporters, ClC-5 is one reasonable candidate. Hence, van den Hove et al. (35) recently suggested that ClC-5 is involved in the apical efflux of iodide. Indeed, ClC-5 is abundantly expressed in the mouse thyroid gland, and its genetic inactivation in Clcn5 knockout mice mimics the thyroidal phenotype of PDS patients (35) . Our observation that ClC-5 is overexpressed in the best compensated zones (zone 1.a) of the PDS thyroid further supports a role for ClC-5 as an apical channel acting as a possible rescue mechanism to preserve the transport of iodide across the apical membrane in the absence of pendrin.
Differences in the efficiency of such compensatory mechanisms may explain the great heterogeneity of thyroid disorders observed among PDS patients, most with only mild thyroid disorders, whereas others may present severe hypothyroidism (5, 17) . These discrepancies could also reflect the insufficiency of compensatory mechanisms to chronically fulfill the role of pendrin, thereby safeguarding at long term the hormone synthesis.
One of the main findings of our paper concerns the ectopic location of thyroid hormone synthesis, as observed in the zone 1.b. At first sight, they appear morphologically normal, but aberrant localization of proteins involved in thyroid hormone synthesis is found. In fact, the data suggest that the whole process of thyroglobulin iodination occurs inside the cells. Thus, in zone 1.b, when T 4 is synthesized into the cytosol instead of the apical membrane, one may suppose that complex biochemical processes relying on H 2 O 2 production may become toxic because they are not strictly constrained at the apical pole. In addition, compared with Tg-I rich follicles, ClC-5 is not as much overexpressed in follicles with no Tg-I accumulation. The synthesis of T 4 still occurs but at a wrong place because inclusions of T 4 are found in the cytosol along with TPO and Duox. Because increased levels of DEHAL1 are observed in these follicles and because this enzyme is also inside the cells, one may expect an increased recycling of iodine, thereby improving its availability. This may eventually compensate partially for the loss of efficiency due to the mislocation of the enzymatic system. Nevertheless, this second compensatory mechanism will also lose its efficiency, likely because it is associated with increased OS, apoptosis, and cell toxicity. Why OS is increased in these conditions remains to be determined, but intracellular H 2 O 2 production associated with intracellular localization of Duox appears as to be a plausible explanation. However, Duox is described as active only when it is localized inside the apical membrane and inactive inside the cytoplasm (40, 41) . Indeed, as already suggested by many studies released over the last decade, the best protection of the thyroid cell against H 2 O 2 is the separation between the iodination system that must take place in microvilli facing the colloid and cytosol (42, 43) . The strict partition of the synthesis system at the apical membrane has been recently reinforced by the concept of the thyroxisome. The thyroxisome corresponds to the clustering of the iodination complex that comprises TPO and Duox together with Cav-1 (38, 44, 45) . They are associated in multimeric complexes that become active once they are integrated into the plasma membrane (40, 41, 44, 46, 47) . Of note, we observed that Cav-1 is absent in the zone 1.b, which may result in the interiorization of the whole process. The availability of iodine being maintained as long as DEHAL1 is active, the thyroid hormone synthesis still occurs but abnormally in the cytosol instead of close to or within the apical membrane. The mechanism of this evolution to interiorization and cell death, and its relation with the absence of a proposed iodide channel is unexplained.
This intracellular synthesis of thyroid hormone is associated with Duoxderived H 2 O 2 and perhaps with other reactive oxygen species that may be harmful for the cell. The increased OSassociated cell toxicity may account for increased apoptosis. However, apoptosis seems, again transiently, compensated by cell proliferation. Similar observations were made in caveolin-1 KO mice (38, 45) . This makes sense knowing that caveolin-1 may inhibit the proliferation of several cell types, including cancer cells (48, 49) , as well as mitogen-activated proliferation (50) . Conversely, the absence of Cav-1 favors cell proliferation (51, 52) . The effect of Cav-1 on cell proliferation may occur via a direct repression of cyclin D1 gene (53) , by inhibiting the p42/44 MAPK or interfering with signal transduction of mitogens as epidermal growth factor (54, 55) . On the other hand, loss of caveolin may protect against OS (56) .
Our recent work has demonstrated the robustness of thyroid cells to resist to OS. In contrast with other cell types such as pancreatic ␤-cells, the antioxidant arsenal of thyroid follicular cells is quite developed and active. They can resist oxidative attacks, as recently demonstrated in animal models of goiter formation and iodine-induced involution (57) . But as soon as the balance between pro-and antioxidant systems is tipping in favor of the former, cell toxicity and destruction occur. It is therefore possible that the outcome of PDS could be ultimately the partial destruction of the thyroid gland and hypothyroidism, especially in patients in whom FIG. 5. Schematic representation of the hypothetical pathophysiological mechanisms leading to morphological and functional alterations in the PDS thyroid. The progression of PDS disease is associated with three different and probably sequential stages. In an initial phase (stage 1, corresponding to zone 1.a), ClC-5 expression is increased, and the expression and location of Duox and TPO, as well as their association, are maintained. The follicles are able to maintain a function close to normal and the cellular oxidative stress is low. Thereafter (stage 2, corresponding to zone 1.b), there is an interiorization of TPO and Duox, associated with the lack of Cav-1. At the same time, ClC-5 expression decreases and is also interiorized. The iodination process takes place within the cell along with increased apoptosis and cell proliferation. The intracellular iodination is associated with an increased oxidative stress. Nevertheless, the thyroid cell is still able to face this intracellular oxidative stress as long as antioxidant systems are potent enough. By the end of the pathological mechanism (stage 3, corresponding to zone 2), cells are unable to face high OS, and proliferation cannot compensate cell death anymore. The thyroid tissue is destroyed and invaded by inflammatory cells that contribute to increase OS. Thyrocytes then become unable to synthesize thyroid hormones. This functionally corresponds to the phase of hypothyroidism. THS, Thyroid hormone synthesis.
alternative mechanisms fail to compensate for the absence of pendrin and when increased OS cannot be anymore buffered by efficient antioxidant defenses. In contrast, other patients facing the same biochemical defect will not become hypothyroid because their thyroid cells may better resist elevated OS and aberrant intracytoplasmic hormone synthesis because of specific genetic background and stronger acquired competences.
In conclusion, our observations suggest that three different and probably sequential stages occur in the course of PDS (Fig. 5) . In an initial phase, follicles maintain a near-normal function, thanks to an increased ClC-5 expression (stage 1). Thereafter associated with the lack of Cav-1, there is an internalizationofthewholethyroidhormonesynthesisandsecretion process and H 2 O 2 intracellular leakage leading to intracellular OS.Aslongasantioxidantsystemsarepotentenoughtofacethe intracellular OS, the iodination process goes on in the cytosol along with increased apoptosis and cell proliferation (stage 2). At the end of the pathological mechanism, when cells are unable to face high OS and when proliferation cannot compensate for cell death, the thyroid tissue is destroyed (stage 3), which functionally corresponds to the phase of hypothyroidism.
